LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
Taking everything into account, LNTH scores 7 out of 10 in our fundamental rating. LNTH was compared to 187 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH is valued quite cheap, while showing a decent growth score. This is a good combination! This makes LNTH very considerable for value and quality investing!
1. Profitability
1.1 Basic Checks
In the past year LNTH was profitable.
LNTH had a positive operating cash flow in the past year.
In multiple years LNTH reported negative net income over the last 5 years.
Each year in the past 5 years LNTH had a positive operating cash flow.
1.2 Ratios
LNTH has a better Return On Assets (12.37%) than 94.65% of its industry peers.
With an excellent Return On Equity value of 21.85%, LNTH belongs to the best of the industry, outperforming 93.58% of the companies in the same industry.
LNTH has a better Return On Invested Capital (18.93%) than 97.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LNTH is significantly above the industry average of 7.89%.
The last Return On Invested Capital (18.93%) for LNTH is above the 3 year average (16.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROIC | 18.93% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of LNTH (16.55%) is better than 93.58% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
LNTH has a Operating Margin of 29.30%. This is amongst the best in the industry. LNTH outperforms 98.40% of its industry peers.
LNTH's Operating Margin has improved in the last couple of years.
LNTH has a better Gross Margin (64.04%) than 66.31% of its industry peers.
LNTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
LNTH has more shares outstanding than it did 5 years ago.
LNTH has a better debt/assets ratio than last year.
2.2 Solvency
LNTH has an Altman-Z score of 6.20. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
LNTH's Altman-Z score of 6.20 is amongst the best of the industry. LNTH outperforms 81.82% of its industry peers.
The Debt to FCF ratio of LNTH is 1.20, which is an excellent value as it means it would take LNTH, only 1.20 years of fcf income to pay off all of its debts.
LNTH has a better Debt to FCF ratio (1.20) than 90.37% of its industry peers.
LNTH has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.49, LNTH perfoms like the industry average, outperforming 41.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 6.2 |
ROIC/WACC2.27
WACC8.34%
2.3 Liquidity
A Current Ratio of 5.74 indicates that LNTH has no problem at all paying its short term obligations.
LNTH has a better Current ratio (5.74) than 81.28% of its industry peers.
A Quick Ratio of 5.46 indicates that LNTH has no problem at all paying its short term obligations.
LNTH has a better Quick ratio (5.46) than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 |
3. Growth
3.1 Past
LNTH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.64%.
The Earnings Per Share has been growing by 42.10% on average over the past years. This is a very strong growth
LNTH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.53%.
Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 34.59% on average per year.
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
3.2 Future
The Earnings Per Share is expected to grow by 7.20% on average over the next years.
LNTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y0.57%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.96, the valuation of LNTH can be described as reasonable.
Based on the Price/Earnings ratio, LNTH is valued cheaper than 93.05% of the companies in the same industry.
LNTH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.29.
Based on the Price/Forward Earnings ratio of 10.48, the valuation of LNTH can be described as reasonable.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaply inside the industry as 91.98% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.74. LNTH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.96 | ||
| Fwd PE | 10.48 |
4.2 Price Multiples
LNTH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LNTH is cheaper than 91.44% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 95.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.58 | ||
| EV/EBITDA | 9.96 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LNTH does not grow enough to justify the current Price/Earnings ratio.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)20.83
PEG (5Y)0.28
EPS Next 2Y5.56%
EPS Next 3Y9.03%
5. Dividend
5.1 Amount
No dividends for LNTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
79.19
-1.23 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners115.61%
Inst Owner Change0.15%
Ins Owners1.3%
Ins Owner Change3.24%
Market Cap5.48B
Analysts82.11
Price Target131.89 (66.55%)
Short Float %13.52%
Short Ratio7.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-9.67%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)-1.14%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)10
Avg EPS beat(12)11.67%
EPS beat(16)14
Avg EPS beat(16)27.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)1%
Revenue beat(12)9
Avg Revenue beat(12)2.39%
Revenue beat(16)13
Avg Revenue beat(16)4.62%
PT rev (1m)-4.16%
PT rev (3m)-3.78%
EPS NQ rev (1m)-1.08%
EPS NQ rev (3m)-2.96%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-4.97%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.96 | ||
| Fwd PE | 10.48 | ||
| P/S | 3.57 | ||
| P/FCF | 11.58 | ||
| P/OCF | 10.43 | ||
| P/B | 4.71 | ||
| P/tB | 5.77 | ||
| EV/EBITDA | 9.96 |
EPS(TTM)6.62
EY8.36%
EPS(NY)7.55
Fwd EY9.54%
FCF(TTM)6.84
FCFY8.63%
OCF(TTM)7.59
OCFY9.58%
SpS22.21
BVpS16.83
TBVpS13.72
PEG (NY)20.83
PEG (5Y)0.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROCE | 24.91% | ||
| ROIC | 18.93% | ||
| ROICexc | 39.39% | ||
| ROICexgc | 52.34% | ||
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% | ||
| FCFM | 30.78% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score8
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 82.91% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.34% | ||
| Profit Quality | 185.99% | ||
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 | ||
| Altman-Z | 6.2 |
F-Score8
WACC8.34%
ROIC/WACC2.27
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
EPS Next Y0.57%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
EBIT growth 1Y-5.08%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year4.08%
EBIT Next 3Y11.97%
EBIT Next 5YN/A
FCF growth 1Y32.98%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y38.18%
OCF growth 3Y116.21%
OCF growth 5Y46.62%